Privi Speciality Chemicals Limited has informed the Exchange that Board of Directors at its meeting held on May 03, 2025, recommended Final Dividend of 5 per equity share.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Privi Speciality Chemicals announced audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, along with an unmodified audit opinion from BSR & Co. LLP. The Board recommended a final dividend of Rs. 5 per share (50%) on a face value of Rs. 10, totaling Rs. 1,953.13 lakhs, subject to shareholder approval at the 40th AGM on August 1, 2025 (record date: July 24, 2025). On a standalone basis, revenue rose to Rs. 2,03,834 lakhs (up ~15% from Rs. 1,77,206 lakhs), and net profit grew to Rs. 25,387 lakhs (up ~30% from Rs. 19,486 lakhs), with EPS of Rs. 64.94. On a consolidated basis, revenue was nearly flat at Rs. 1,77,795 lakhs, but net profit jumped to Rs. 18,161 lakhs from Rs. 9,491 lakhs. BSR & Co. LLP was re-appointed as statutory auditors for a second 5-year term, and Rathi & Associates was appointed as secretarial auditor for FY2025-26 to FY2029-30.
Strong earnings growth on both standalone and consolidated bases, combined with a 50% dividend payout, signals healthy cash generation and shareholder-friendly capital allocation, likely to be viewed positively by the market.